Θεόδωρος Καραμπιτσάκος

Ειδικευμένος Ιατρός

kara e1648799358941

EDUCATION/TRAINING

INSTITUTION AND LOCATIONDEGREEYEAR(s)FIELD OF STUDY
Democritus University of Thrace, Medical School, GreeceMD (7.53/10)1/9/2009-13/7/2015Medicine
Democritus University of Thrace, Medical School, GreeceMSc
(9/10)		30/1/2016- 18/10/2017Clinical Pharmacology and Therapeutics
National and Kapodistrian University of Athens, GreecePhD1/2/2018Immune insights in Interstitial lung diseases

Α. Personal Statement

Theodoros Karampitsakos was born on 20.11.1991 and completed his primary and secondary education in Thebes with the grade of ‘’excellence 19.6/20’’. As a student, he won the award ‘’ Thales’’ in the National Mathematic Contest of the Hellenic Mathematical Society (HMS) in 2006, 2007, 2008. Theodoros Karampitsakos graduated from the School of Medicine, Democritus University of Thrace, Greece in 2015 with the grade of ‘’ very good 7.53/10 ’’. He has also completed his MSc studies in the ‘’ Clinical Pharmacology and Therapeutics’’ in the Democritus University of Thrace with the grade of ‘’ excellence 9/10’’. He has been a resident in the Pulmonary Medicine, Sotiria Chest Hospital, Athens until 16/3/2020. He is currently a PhD student in National and Kapodistrian University of Athens and he is continuing his residency in University of Patras, Department of Respiratory Medicine. During his spell in Sotiria, he has performed over 600 bronchoscopies and 120 EBUS-TBNB in the 5th Department of Respiratory Medicine of Sotiria. Theodoros Karampitsakos completed his residency/fellowship in the Department of Respiratory Medicine, University Hospital of Patras in 5/11/2021. During his spell in University Hospital of Patras, he has performed over 300 bronchoscopies.

Theodoros A. Karampitsakos’ main research interest is pulmonary fibrosis and its pathogenesis. He has participated in trials enrolling patients with idiopathic pulmonary fibrosis in the Department of Pulmonology, Medical School, Democritus University of Thrace, Greece and in the Sotiria Chest Hospital, Athens under the supervision of Demosthenes Bouros and Argyrios Tzouvelekis. He has also participated in studies regarding exhaled nitric oxide in Democritus University of Thrace. Theodoros Karampitsakos has also completed an elective rotation program (4/2015-5/2015) in the Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine at Yale New Haven Hospital, USA under the supervision of professors Naftali Kaminski, Charles Dela Cruz, Erica Herzog, Geoffrey Chupp and Isahaar Ben-Dov in the Winchester Clinic, Yale University, New Haven.

Positions

Oct 2015 – Oct 2016- Rural doctor (mandatory service), Tertiary Hospital of Karditsa, Greece

Dec 2016 – March 2020 Resident in Pulmonology, Hospital for Diseases of the Chest, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, Greece

May 2020 – November 2021 Resident, University of Patras, Department of Respiratory Medicine

November 2021 – University Hospital of Patras, Department of Respiratory Medicine

Reviewer

Respiratory Research, Frontiers in Medicine, ERJ open research, BMC pulmonary medicine, International Journal of COPD

Guest Associate Editor

Frontiers in Medicine – Research topic – Immune mediated lung injury

Awards

Winner of the Award ‘’ Thales’’ in the National Mathematic Contest of the Hellenic Mathematical Society (HMS) in 2006, 2007, 2008

Research Awards in the National Congress of Hellenic Thoracic Society:

Award for research project: 2017, 2020

Award for best presentation in Interstitial Lung Diseases: 2019, 2021

Language

Deutsch (level B2), English (level C2), French (level B2), Greek (native speaker)

B. Publications

  1. Total Number of Publications in a Journal: 63 (55 PubMed) 
  2. First author in publications of Pubmed (total articles): 22 (6 of them with asterisk of equal contribution)
  3. First author original research articles: 11 (4 of them with asterisk of equal contribution)
  4. h-index: 15 (Google Scholar)

Publications in Peer-Reviewed Journals of Pubmed

  1. Karampitsakos T, Papaioannou O, Dimeas I, Tsiri P, Sotiropoulou V, Tomos I, Papanikolaou IC, Katsaras M, Kirgou P, Daniil Z, Gourgoulianis KI, Sampsonas F, Manali E, Papiris S, Bouros D, Tzouvelekis A. Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis ERJ Open Research 2022 research letter
  2. Sampsonas F, Karamouzos V, Karampitsakos T, Papaioannou O, Katsaras M, Lagadinou M, Zarkadi E, Malakounidou E, Velissaris D, Stratakos G, Tzouvelekis A. High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis Front Med (Lausanne) 2022 Feb meta-analysis
  3. Doulberis M, Sampsonas F, Papaefthymiou A, Karamouzos V, Lagadinou M, Karampitsakos T, Stratakos G, Kuntzen T, Tzouvelekis A. High-flow versus conventional nasal cannula oxygen supplementation therapy and risk of hypoxia in gastrointestinal endoscopies: a systematic review and meta-analysis Expert Rev Respir Med 2022 Feb meta-analysis
  4. Manali ED, Kannengiesser C, Borie R, Ba I, Bouros D, Markopoulou A, Antoniou K, Kolilekas L, Papaioannou AI, Tzilas V, Tzouvelekis A, Daniil Z, Fouka E, Papakosta D, Xyfteri A, Karakatsani A, Loukides S, Korbila I, Tomos IP, Konstantinidis AK, Gogali A, Steiropoulos P, Papanikolaou IC, Bazaka C, Haritou A, Vassilakopoulos T, Maniati M, Kagouridis K, Markozannes E, Bouros E, Rampiadou C, Kounti G, Trachalaki A, Dimeas I, Karampitsakos T, Lyberopoulos P, Malamadakis N, Spyropoulou S, Revy P, Lainey E, Dieudé P, Rebah K, Ménard C, Oudin C, Masson C, Plessier A, Legendre M, Nathan N, Coulomb-L’Hermine A, Clement A, Amselem S, Boileau C, Crestani B, Papiris S; Greek Group of ILD Investigators. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study Respiration 2022 Original research article
  5. Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, Tsiri P, Tsirikos G, Georgiopoulou V, Oikonomou I, Davoulos C, Velissaris D, Sampsonas F, Marangos M, Akinosoglou K, Tzouvelekis A. Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study Respir Res 2021 Original research article
  6. Ntatsoulis K*, Karampitsakos T*, Tsitoura E, Stylianaki EA, Matralis AN, Tzouvelekis A, Antoniou K, Aidinis V. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target Front Immunol 2021 Review article, equal contribution
  7. Papaioannou O, Karampitsakos T, Katsaras M, Sampsonas F, Tzouvelekis A. Clinical improvement in Job syndrome following administration of co-trimoxazole, omalizumab and inhaled tobramycin Adv Respir Med 2021 Case report
  8. Karampitsakos T, Papaioannou O, Sampsonas F, Tzouvelekis A. Infliximab-induced interstitial lung disease BMJ case reports 2021 Case report
  9. Karampitsakos T, Kalogeropoulou C, Tzilas V, Papaioannou O, Kazantzi A, Koukaki E, Katsaras M, Bouros E, Tsiri P, Tsirikos G, Zarkadi E, Ntoulias N, Sotiropoulou V, Efthymiou P, Chrysikos S, Malakounidou E, Sampsonas F, Bouros D, Tzouvelekis A. Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model Respiration 2021 Original research article
  10. Sampsonas F, Katsaras M, Papaioannou O, Karampitsakos T, Lakkas L, Michalis LK, Tzouvelekis A. Platypnea orthodeoxia syndrome in a patient with patent foramen ovale and normal atrial pressure. Case report and presentation of underlying pathophysiological mechanisms Monaldi Arch Chest Dis 2021 Case report
  11. Tzouvelekis A*, Akinosoglou K*, Karampitsakos T*, Panou V, Tomos I, Tsoukalas G, Stratiki M, Dimakou K, Chrysikos S, Papaioannou O, Hillas G, Bakakos P, Stratakos G, Anagnostopoulos A, Koromilias A, Boutou A, Kioumis I, Chloros D, Kontakiotis T, Papakosta D, Papiris S, Manali E, Antonogiannaki EM, Koulouris N, Bouros D, Loukides S, Gogos C. Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic Original research article equal contribution
  12. Karampitsakos T, Papaioannou O, Katsaras M, Sampsonas F, Tzouvelekis A. Interstitial Lung Diseases and the Impact of Gender Clin Chest Med 2021 Review article
  13. Sampsonas F, Lagadinou M, Karampitsakos T, Solomou E, Doulberis M, Marangos M, Tzouvelekis A. Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection Eur Rev Med Pharmacol Sci 2021 Review article
  14. Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, Sampsonas F, Katsaras M, Vasarmidi E, Papakosta D, Domvri K, Fouka E, Organtzis I, Daniil Z, Dimeas I, Kirgou P, Gourgoulianis KI, Papanikolaou IC, Markopoulou K, Kounti G, Tsapakidou E, Papadopoulou E, Tatsis K, Gogali A, Kostikas K, Tzilas V, Chrysikos S, Papiris S, Bouros D, Kreuter M, Tzouvelekis A. Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis Respir Res 2021 Original research article
  15. Kyriakopoulos C, Gogali A, Exarchos K, Potonos D, Tatsis K, Apollonatou V, Loukides S, Papiris S, Sigala I, Katsaounou P, Aggelidis M, Fouka E, Porpodis K, Kontakiotis T, Sampsonas F, Karampitsakos T, Tzouvelekis A, Bibaki E, Karagiannis K, Antoniou K, Tzanakis N, Dimeas I, Daniil Z, Gourgoulianis K, Kouratzi M, Steiropoulos P, Antonakis E, Papanikolaou IC, Ntritsos G, Kostikas K. Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece. Respiration. 2021 Original research article
  16. Sampsonas F, Kakoullis L, Karampitsakos T, Papaioannou O, Katsaras M, Papachristodoulou E, Kyriakou G, Bellou A, Tzouvelekis A. Bronchoscopy during the COVID-19 pandemic: effect on current practices and strategies to reduce procedure-associated transmission Expert Rev Respir Med 2021 Review article
  17. Kostikas K, Papathanasiou E, Papaioannou AI, Bartziokas K, Papanikolaou IC, Antonakis E, Makou I, Hillas G, Karampitsakos T, Papaioannou O, Dimakou K, Apollonatou V, Verykokou G, Papiris S, Bakakos P, Loukides S. Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study Biomarkers 2021 Original research article
  18. Tzouvelekis A, Antoniou K, Kreuter M, Evison M, Blum TG, Poletti V, Grigoriu B, Vancheri C, Spagnolo P, Karampitsakos T, Bonella F, Wells A, Raghu G, Molina-Molina M, Culver DA, Bendstrup E, Mogulkoc N, Elia S, Cadranel J, Bouros D. The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus ERJ Open Res 2021 Original research article
  19. Karampitsakos T, Akinosoglou K, Papaioannou O, Panou V, Koromilias A, Bakakos P, Loukides S, Bouros D, Gogos C, Tzouvelekis A. Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study. Front Med (Lausanne). 2020 Original research article
  20. Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacol Ther. 2021 Review article
  21. Papiris SA, Bouros D, Markopoulou K, Kolilekas L, Papaioannou AI, Tzilas V, Tzouvelekis A, Fouka E, Papakosta D, Daniil Z, Steiropoulos P, Gogali A, Papanikolaou IC, Xyfteri A, Haritou A, Korbila I, Tomos IP, Loukides S, Bellelli R, Kounti G, Rampiadou C, Karampitsakos T, Dimeas I, Kirgou P, Bompoki A, Vasarmidi E, Loverdos K, Antonogiannaki EM, Blizou M, Bouros E, Kagouridis K, Maniati M, Karakatsani A, Antoniou KM, Manali ED. Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation.  Eur Respir J. 2021 Research letter
  22. Tzilas V, Tzouvelekis A, Bouros E, Karampitsakos T, Ntassiou M, Avdoula E, Trachalaki A, Antoniou K, Raghu G, Bouros D. Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study. ERJ Open Res. 2020 Original research article
  23. Chrysikos S, Gkiozos I, Dimakou K, Zervas E, Karampitsakos T, Anyfanti M, Tzouvelekis A, Samitas K, Gaga M, Koulouris N, Vasileiadis I, Syrigos K. Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT-a real-life prospective study in Greece J Thorac Dis 2020 Original research article
  24. Chrysikos S, Papaioannou O, Anyfanti M, Karampitsakos T, Vamvakaris I, Tzouvelekis A, Dimakou K. A 52-Year-Old Man Presented With Cough, Chest Pain, and a Mass in the Right Lung.  Chest 2020 Case report
  25. Ntolios P, Steiropoulos P, Karpathiou G, Anevlavis S, Karampitsakos T, Bouros E, Froudarakis ME, Bouros D, Tzouvelekis A. Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date BioDrugs. 2020 Review article
  26. Chrysikos S, Karampitsakos T, Zervas E, Anyfanti M, Papaioannou O, Tzouvelekis A, Hillas G, Dimakou K. Thoracic endosonography (EBUS/EUS-b) in diagnosis of different intrathoracic diseases: a 4-year experience at a single-center in Greece Int J Clin Pract 2020 Original research article
  27. Tzouvelekis A, Karampitsakos T, Krompa A, Markozannes E, Bouros D False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis Front Med (Lausanne). 2020 Case Report
  28. Tzouvelekis A, Karampitsakos T, Bouros D The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity Front Med (Lausanne). 2020 Opinion
  29. Tzouvelekis A*, Karampitsakos T*, Kourtidou S, Bouros E, Tzilas V, Katsaras M, Antonou C, Dassiou M, Bouros D Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis Front Med (Lausanne). 2020 * means equal contribution as first authors Original research article
  30. Karampitsakos T, Papaioannou O, Kaponi M, Kozanidou A, Hillas G, Stavropoulou E, Bouros D, Dimakou K Low penetrance of antibiotics in the epithelial lining fluid. The role of inhaled antibiotics in patients with bronchiectasis Pulm Pharmacol Ther. 2020 Review article
  31. Karampitsakos T, Hillas G, Zervas E, Bakakos P, Stratakos G, Dimakou K, Manali E, Bouros D, Papiris S, Tzouvelekis A; PAIR study investigators Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study Pulm Pharmacol Ther. 2020 Original research article
  32. Tzouvelekis A*, Karampitsakos T*, Gomatou G, Bouros E, Tzilas V, Manali E, Tomos I, Trachalaki A, Kolilekas L, Korbila I, Tomos P, Chrysikos S, Gaga M, Daniil Z, Bardaka F, Papanikolaou IC, Euthymiou C, Papakosta D, Steiropoulos P, Ntolios P, Tringidou R, Papiris S, Antoniou K, Bouros D Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece Pulm Pharmacol Ther. 2020 * means equal contribution as first authors Original research article
  33. Karampitsakos T, Dimakou K, Papaioannou O, Chrysikos S, Kaponi M, Bouros D, Tzouvelekis A, Hillas G The role of increased red cell distribution width as a negative prognostic marker in patients with COPD Pulm Pharmacol Ther. 2020 Original research article
  34. Xylourgidis N, Min K, Ahangari F, Yu G, Herazo-Maya JD, Karampitsakos T, Aidinis V, Binzenhöfer L, Bouros D, Bennett AM, Kaminski N, Tzouvelekis A Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol. 2019 Original research article
  35. Tzouvelekis A, Karampitsakos T, Bouros E, Tzilas V, Liossis SN, Bouros D Autoimmune Biomarkers, Antibodies, and Immunologic Evaluation of the Patient with Fibrotic Lung Disease Clin Chest Med. 2019 Review article
  36. Tzilas V, Tzouvelekis A, Bouros E, Karampitsakos T, Ntasiou M, Katsaras M, Costabel U, Wells A, Bouros D Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern Eur Respir J. 2019 Research Letter
  37. Protopapas AA, Vradelis S, Karampitsakos T, Steiropoulos P, Chatzimichael A, Paraskakis E Elevated Levels of Alveolar Nitric Oxide May Indicate Presence of Small Airway Inflammation in Patients with Inflammatory Bowel Disease Lung. 2019 Original research article
  38. Karampitsakos T, Vraka A, Bouros D, Liossis SN, Tzouvelekis A Biologic Treatments in Interstitial Lung Diseases Front Med (Lausanne). 2019 Review article
  39. Schoini P, Karampitsakos T, Avdikou M, Athanasopoulou A, Tsoukalas G, Tzouvelekis A Measles pneumonitis  Adv Respir Med. 2019 Case Report
  40. Tzilas V, Bouros E, Barbayianni I, Karampitsakos T, Kourtidou S, Ntassiou M, Ninou I, Aidinis V, Bouros D, Tzouvelekis A. Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 2019 Original research article
  41. Chrysikos S, Karampitsakos T, Tzouvelekis A, Dimakou K. Endobronchial metastasis from renal cell carcinoma as a reason for recurrent pulmonary infections. Adv Respir Med. 2018 Case Report
  42. Chrysikos S, Karampitsakos T, Tzouvelekis A, Dimakou K Coexistence of Sarcoidosis and Trachebronchopathia Osteochondroplastica Journal of Bronchology & Interventional Pulmonology 2018  Case Report
  43. Almendros I, Alsafadi HN, Bölükbas D, Collins JJP, Duch P, Garrido-Martin EM, Kahn N, Karampitsakos T, Mahmutovic Persson I, Tzouvelekis A, Uhl FE, Bartel S Early Career Members at the ERS Lung Science Conference: cell-matrix interactions in lung disease and regeneration: Early career forum Breathe (Sheff). 2018 Review article
  44. Tzouvelekis A*, Toonkel R*, Karampitsakos T*, Medapalli K, Ninou I, Aidinis V, Bouros D, Glassberg MK. Front Med (Lausanne). 2018  *  means equal contribution as first authors Review article
  45. Karampitsakos T, Tzouvelekis A, Chrysikos S, Bouros D, Tsangaris I, Fares WH Pulmonary hypertension in patients with interstitial lung disease Pulm Pharmacol Ther. 2018 Review article
  46. Chrysikos S, Kaponi M, Triantafillidou C, Karampitsakos T, Tzouvelekis A, Anyfanti M, Marossis K, Konstantinou M, Tringidou R, Bouros D, Dimakou K A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass Front Oncol 2018 Case Report
  47. Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, Bouros D, Aidinis V, Tzouvelekis A Front Med (Lausanne). 2018 Review Article
  48. Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study Pulm Pharmacol Ther 2018 Original research article equal contribution
  49. Tzouvelekis A*, Karampitsakos T*, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D Longitudinal “real-world” outcomes of pirfenidone in Idiopathic Pulmonary Fibrosis in Greece. Frontiers in Medicine 2017 Accepted for publication Original article (* means these authors contributed equally to work)
  50. Karampitsakos T, Protopapas A, Gianoloudi M, Papadopoulos VP, Bouros D, Chatzimichael A, Paraskakis E. The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (CANO) in children and young adults. J Asthma 2017 Original research article
  51. Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D. Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study. Pulm Pharmacol Ther 2017 Original research article
  52. Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A. Lung cancer in patients with idiopathic pulmonary fibrosis Pulm Pharmacol Ther 2017 Review article
  53. Karampitsakos T, Woolard T, Bouros D, Tzouvelekis A. Toll-like receptors in the pathogenesis of lung fibrosis. Eur J Pharmacol 2017 Review article
  54. Karampitsakos T, Gourgoulianis KI Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD? Med Hypotheses 2016 Review article
  55. Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D Greek Physicians’ Perceptions on Generic Drugs in the Era of Austerity , Scientifica 2015;2015:251792 Original research article

Publications in the Greek Journal of Pneumonology ‘’Pneumon’’

  1. Karampitsakos T, Koukaki E, Tzouvelekis A, Tzilas V,  Bouros E, Dassiou M, Bouros D Depression, antidepressants and pulmonary embolism Pneumon 2018
  2. Karampitsakos T, Chrysikos S, Tzilas V, Dimakou K, Bouros D, Tzouvelekis A Idiopathic Pulmonary Fibrosis. Time to get personal Pneumon 2018
  3. Karampitsakos T, Melachroinidou M, Kaponi M, Chrysikos S, Tzouvelekis A, Bouros D,  Dimakou K Cystic Bronchiectasis in a 38 year old female Pneumon 2017 Case Report
  4. Karampitsakos T, Dimakou K, Bouros D Role of aquatic therapy and speleotherapy as complementary therapies in the respiratory system Pneumon 2017 Review article
  5. Karampitsakos T, Bouros D, Tzouvelekis A New targets for the therapy of Pulmonary Arterial Hypertension (PAH) Nebulized anti-miRs against miR-138 and miR-25 completely regress monocrotaline-induced PAH Pneumon 2016 Commentary
  6. Karampitsakos T, Bouros D Consensus Task Force recommendations for evaluation and management of Eosinophilic granulomatosis with polyangiitis syndrome (Churg–Strauss) Pneumon 2016 Review article
  7. Ntolios P, Karampitsakos T, Bouros D Desquamative Interstitial Pneumonia ,Pneumon Journal 2014 Case Report

Presentations in International Conferences

  1. Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosisPaschalis Ntolios, Andreas Koulelidis, Georgios Zacharis, Argyrios Tzouvelekis, Panagiotis Boglou, Konstantinos Kaltsas, Evangelos Bouros, Theodoros Karampitsakos, Maria Karailidou, Paschalis Steiropoulos, Marios Froudarakis, and Demosthenes Bouros Published in 2014 in European Respiratory Journal 44 ( ERS International Conference 2014, Berlin)
  2. Clinical findings at initial presentation of IPF patients at a university hospital referral center Paschalis Ntolios, Georgios Zacharis, Argyrios Tzouvelekis, Panagiotis Boglou, Evangelos Bouros, Konstantinos Kaltsas, Maria Karailidou, Theodoros Karampitsakos, Paschalis Steiropoulos, Marios Froudarakis, and Demosthenes Bouros Published in 2014 in European Respiratory Journal 44 ( ERS International Conference 2014, Berlin)
  3. Sleep quality among patients with idiopathic pulmonary fibrosisPaschalis Ntolios, Theodoros Karampitsakos, Maria Karailidou, Maria Xanthoudaki, Evangelia Nena, Despoina Kotakidou, Stavros Anevlavis, Marios Froudarakis, Demosthenes Bouros, and Paschalis Steiropoulos Published in 2015 in European Respiratory Journal 46 ( ERS International Conference 2015, Amsterdam)
  4. The effect of bronchodilation and spirometry on exhaled nitric oxide in patients with asthma and healthy volunteersKarampitsakos T, Paraskakis E., Protopapas A., Giasari P., Triantafyllidou E., Ramatani A., Tsalkidis A ,Chatzimichael A. Greek National Conference 2016 Thessaloniki Oral Presentation
  5. The effect of bronchodilation and spirometry on exhaled nitric oxide in patients with asthma and healthy volunteersKarampitsakos T, Paraskakis E., Protopapas A., Giasari P., Triantafyllidou E., Ramatani A., Tsalkidis A ,Chatzimichael A. ERS 2016 London
  6. Elevated levels of alveolar nitric oxide in patients with inflammatory bowel diseaseProtopapas A, Vradelis S, Karampitsakos T, Chatzimichail A, Paraskakis E ERS 2016 London
  7. Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D ERS 2017 Milan
  8. Impact of cancer in patients with pulmonary fibrosis Tzouvelekis A, Kolilekas L, Bouros E, Karampitsakos T,  Tzilas V, Koulouris N, Bouros D ERS 2017 Milan
  9. Impact of depression in patients with pulmonary fibrosis Tzouvelekis A, Kourtidou S, Bouros E, Karampitsakos T, Tzilas V, Steiropoulos P, Koulouris N, Bouros D ERS 2017 Milan
  10. Role of Mitogen activated-kinase (MAPK)-phosphatase (MKP)-5 in pulmonary fibrosis A Tzouvelekis, T Karampitsakos, K Min, N Xylourgidis, G Yu, J Herazo-Maya, L Bizenhofer, A Bennett, N Kaminski Lung Science 2018 Estoril
  11. Bronchiectasis contributes to the severity of COPD Aikaterini Dimakou, Maria Kaponi, Kyriaki Tsikritsaki, Anna Gousiou, Serafeim Chrysikos, Georgios Hillas, Xristina Triantafyllidou, Theodoros Karampitsakos, Loukas Thanos, Michail Toumbis ERS 2018
  12. Red cell distribution width on admission correlates with the need of application of Non Invasive Mechanical Ventilation in Acute Exacerbation of COPD Theodoros Karampitsakos, Argyrios Tzouvelekis, Ourania Papaioannou, Serafeim Chrysikos, Demosthenes Bouros, Katerina Dimakou, Georgios Hillas ERS 2019 Madrid
  13. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Theodoros Karampitsakos, Georgia Gomatou, Vasilios Tzilas, Evangelos Bouros, Evangelos Markozannes, Effrosyni Manali, Ioannis Tomos, Katerina Antoniou, Athina Trachalaki, Lykourgos Kolilekas, Ioanna Korbila, Periklis Tomos, Serafeim Chrysikos, Katerina Dimakou, Konstantinos Loverdos, Asimina Gaga, Zoe Daniil, Fotini Bardaka, Ilias Papanikolaou, Despoina Papakosta, Katerina Markopoulou, Rodoula Tringidou, Spyridon Papiris, Demosthenes Bouros, Argyris Tzouvelekis ERS 2019 Madrid
  14. SH2 domain-containing Phosphatase-(SHP)-2 blunts fibrotic responses through regulation of fibroblast mitochondrial metabolism and autophagy Argyris Tzouvelekis, Guoyin Yu, Farida Ahangari, Anton Bennett, Theodoros Karampitsakos, Demosthenes Bouros, Evangelos Bouros, Naftali Kaminski ERS 2019 Madrid
  15. Subtypes of lung adenocarcinomas associated with IPF Georgia Gomatou, Rodoula Tringidou, Thodoris Karampitsakos, Vasilios Tzilas, Argyrios Tzouvelekis, Demosthenes Bouros ERS 2019 Madrid
  16. Increased Red Cell Distribution Width and Absolute Number of Monocytes Represent Negative Prognostic Markers in Patients with Idiopathic Pulmonary FibrosisT. Karampitsakos, E. Bouros, A. Anagnostopoulos, K. Cholidou, V. Panou, A. Korba, V. Tzilas, E. Koukaki, E. Markozannes, D. Bouros, A. Tzouvelekis ATS 2020
  17. The DIAMORFOSIS (Diagnosis and Management of Lung Cancer and Fibrosis) Survey A.E. Tzouvelekis , K. Antoniou , M. Kreuter , M. Evison , T. Karampitsakos , T. Blum , V. Poletti , P. Spagnolo , F. Bonella , B.D. Grigoriu , C. Vancheri , J. Cadranel , D. Bouros ATS 2020
  18. Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis.T. Karampitsakos, S. Torrisi, K. Antoniou, E. Bouros, I. Korbila, E. Manali, E. Vasarmidi, D. Papakosta, K. Domvri, Z. Daniil, I. Dimeas, P. Kirgou, I. Papanikolaou, E. Bibaki, K. Markopoulou, G. Kounti, E. Tsapakidou, E. Papadopoulou, S. Papiris, D. Bouros, M. Kreuter, A. Tzouvelekis ERS 2020
  19. Safety and effectiveness of mycophenolate mofetil in interstitial lung diseasesTheodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, Evangelia Koukaki, Matthaios Katsaras, Evangelos Bouros, Panagiota Tsiri, Georgios Tsirikos, Eirini Zarkadi, Nikolaos Ntoulias, Vasilina Sotiropoulou, Panagiotis Efthymiou, Serafeim Chrysikos, Elli Malakounidou, Fotios Sampsonas, Christina Kalogeropoulou, Demosthenes Bouros, Argyris Tzouvelekis ERS 2021
  20. Clinical features and outcomes of patients with myositis associated-interstitial lung disease Theodoros Karampitsakos, Ourania Papaioannou, Serafeim Chrysikos, Matthaios Katsaras, Georgios Tsirikos,  Panagiota Tsiri, Eirini Zarkadi, Panagiotis Efthymiou, Vasilina Sotiropoulou, Nikolaos Ntoulias, Elli Malakounidou, Aggeliki Bellou, Vassilios Tzilas, Fotios Sampsonas, Theofanis Karageorgas, Katerina Dimakou, Demosthenes Bouros, Argyris Tzouvelekis ERS 2021
  21. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe.Theodoros Karampitsakos, Nesrin Mogulkoc, Michael Kreuter, Wim A. Wuyts, Sara Tomassetti, Elisabeth Bendstrup, Maria Molina-Molina, Paolo Spagnolo, Effrosyni D. Manali, Ömer Selim Unat, Nicolas Kahn, Lykourgos Kolilekas, Elisabetta Rosi, Leonardo Gori,  Claudia Ravaglia, Zoe Daniil, Thomas Skovhus Prior, Ilias C. Papanikolaou, Samantha Aso, Stavros Tryfon, Despoina Papakosta, Elisabetta Balestro, Spyridon Papiris, Katerina Antoniou, Demosthenes Bouros, Argyris Tzouvelekis ERS 2021
  22. Differential expression of PD-1/PD-L1 axis and CD4/CD8 ratio in mediastinal lymph nodes of patients with idiopathic pulmonary fibrosis and lung cancerTheodoros Karampitsakos, Serafeim Chrysikos, Ioannis Vamvakaris, Ourania Papaioannou, Evangelos Bouros, Aris Anagnostopoulos, Matthaios Katsaras, Katerina Dimakou, Effrosyni D. Manali, Spyridon Papiris, Demosthenes Bouros, Petros Bakakos,  Argyris Tzouvelekis ERS 2021
  23. Biosynthesis and implementation of Thyroid Receptor beta (TRβ) agonists (thyromimetics) for the treatment of pulmonary fibrosisAlexios Matralis, Theodoros Karampitsakos, Ourania Papaioannou, Matthaios Katsaras, Fotios Sampsonas, Demosthenes Bouros, Vassilis Aidinis, Argyris Tzouvelekis ERS 2021
  24. Tocilizumab in hospitalized patients with severe COVID-19: an open label, prospective study Theodoros Karampitsakos, Elli Malakounidou, Ourania Papaioannou, Vasilina Dimakopoulou, Eirini Zarkadi, Matthaios Katsaras, Panagiota Tsiri, Georgios Tsirikos, Ioanna Oikonomou, Christos Davoulos, Vasiliki Georgiopoulou, Fotios Sampsonas, Markos Marangos, Karolina Akinosoglou, Argyris Tzouvelekis ERS 2021

Books

  1. Current medical approaches (Greek book), Chapter: Long Covid, 2021
  2. Clinical Pulmonology (Greek book), Chapter: Pathogenesis of interstitial lung diseases, 2021
  3. Clinics in Chest Medicine, Chapter: Interstitial Lung Diseases and the Impact of Gender, 2021

Invited speaker

  1. Asthma seminar of Hellenic Thoracic Society 2021, Presentation: Hypereosinophilic syndrome
  2. Greek ILD seminar 2021, Presentation: Fanconi syndrome
  3. Greek ILD seminar 2021, Presentation: Myositis-ILD cases
  4. Greek ILD seminar 2021, Presentation: Lung cancer in IPF
  5. Greek ILD seminar 2021, Presentation: Parameters of complete blood count as a biomarker in IPF
  6. Greek ILD seminar 2019, Presentation: Infliximab induced interstitial lung disease
  7. Greek ILD seminar 2018, Presentation: Sarcoidosis cases
  8. Greek ILD seminar 2017, Presentation: P-anca vasculitis cases

Referees

  • Argyrios Tzouvelekis –  Associate Professsor of Internal and Respiratory Medicine, University of Patras, Greece
  • Demosthenes Bouros – Professor of Pneumonology , First Academic Department of Pneumonology, General Hospital for Thoracic Diseases “SOTIRIA”,Medical School, National and Kapodistrian University of Athens
  • Isahaar Ben-Dov – Clinician in Medicine, Department of Internal Medicine, Section of Pulmonary Critical Care and Sleep Medicine, Yale School of Medicine, CT, USA
  • Dimakou Katerina, 5th Department of Pneumonology, General Hospital for Thoracic Diseases “SOTIRIA”, Athens, Greece
  • Marossis Konstantinos, 5th Department of Pneumonology, General Hospital for Thoracic Diseases “SOTIRIA”, Athens, Greece
  • Chrysikos Serafeim, 5th Department of Pneumonology, General Hospital for Thoracic Diseases “SOTIRIA”, Athens, Greece